Jan Korabecny
Hradec Kralove, KR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 170 publications
Quaternary ammonium compounds: outdated or relevant antiviral agents? A narrative review of QAC efficacy against enveloped and non-enveloped viruses.
Journal: Critical reviews in microbiology
Published: September 04, 2026
Carltonine B derivatives: Synthesis and structure-activity relationship insights for selective butyrylcholinesterase inhibition.
Journal: Bioorganic chemistry
Published: February 11, 2026
The role of 5-HT3 receptors in schizophrenia and associated depressive and addictive comorbidities.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: February 06, 2026
Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host-Directed Strategies.
Journal: Medicinal research reviews
Published: December 09, 2025
Next-generation broad-spectrum reactivators for effective countermeasure against organophosphorus poisoning.
Journal: Archives of toxicology
Published: October 29, 2025
Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case Studies.
Journal: Journal of medicinal chemistry
Published: October 07, 2025
Reactivation screening of A-234-inhibited human recombinant acetylcholinesterase in vitro.
Journal: Chemico-biological interactions
Published: August 28, 2025
Balancing rigidity and flexibility: Optimised 4-(hexyloxy)benzoate antagonists with enhanced affinity and tuneable duration at muscarinic receptors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 29, 2025
Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidines.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 23, 2025
Novel pyrimidine derivatives as promising antimycobacterial agents.
Journal: European journal of medicinal chemistry
Published: May 24, 2025
Novel tacrine-based multi-target directed Ligands: Enhancing cholinesterase inhibition, NMDA receptor antagonism, and CNS bioavailability for Alzheimer's disease treatment.
Journal: European journal of medicinal chemistry
Published: March 05, 2025
Last Updated: 09/26/2026